Cargando…

Population pharmacokinetics, enzyme occupancy, and 24S‐hydroxycholesterol modeling of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, in healthy adults

Soticlestat is a first‐in‐class, selective inhibitor of cholesterol 24‐hydroxylase (CH24H), which catabolizes cholesterol to 24S‐hydroxycholesterol (24HC) in the brain, in phase III development for Dravet syndrome and Lennox–Gastaut syndrome treatment. This study aimed to develop a model of soticles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Wei, Facius, Axel, Wagner, Thomas, Tsai, Max, Asgharnejad, Mahnaz, Lahu, Gëzim, Vakilynejad, Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339692/ https://www.ncbi.nlm.nih.gov/pubmed/37212649 http://dx.doi.org/10.1111/cts.13517

Ejemplares similares

Anticonvulsive properties of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor
por: Nishi, Toshiya, et al.
Publicado: (2022)

Clinical Characterization of [(18)F]T-008, a Cholesterol 24-Hydroxylase PET Ligand: Dosimetry, Kinetic Modeling, Variability, and Soticlestat Occupancy
por: Constantinescu, Cristian C., et al.
Publicado: (2023)

Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
por: Nishi, Toshiya, et al.
Publicado: (2020)

Soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice
por: Hawkins, Nicole A., et al.
Publicado: (2021)

Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia
por: Chiappelli, Joshua, et al.
Publicado: (2020)

Pharmacokinetic and Pharmacodynamic Modelling to Characterize the Tolerability of Alternative Up-Titration Regimens of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease
por: Facius, Axel, et al.
Publicado: (2018)

Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations
por: Plock, Nele, et al.
Publicado: (2014)

Randomized controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in adults with complex regional pain syndrome
por: Ratcliffe, Stuart, et al.
Publicado: (2022)

Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse
por: Meljon, Anna, et al.
Publicado: (2014)

Quantitative detection of free 24S-hydroxycholesterol, and 27-hydroxycholesterol from human serum
por: Bandaru, Veera Venkata Ratnam, et al.
Publicado: (2014)

A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure
por: Scarpignato, Carmelo, et al.
Publicado: (2022)

Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers
por: Wang, Shining, et al.
Publicado: (2022)

The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer’s Disease
por: Gamba, Paola, et al.
Publicado: (2021)

Induction of apoptosis and necroptosis by 24(S)-hydroxycholesterol is dependent on activity of acyl-CoA:cholesterol acyltransferase 1
por: Yamanaka, K, et al.
Publicado: (2014)

Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis
por: Tsitsou-Kampeli, Afroditi, et al.
Publicado: (2023)

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques
por: Rodriguez‐Romero, Violeta, et al.
Publicado: (2019)

Cholesterol 25-hydroxylase negatively regulates porcine intestinal coronavirus replication by the production of 25-hydroxycholesterol
por: Zhang, Yunhang, et al.
Publicado: (2019)

Cholesterol 25-hydroxylase suppresses avian reovirus replication by its enzymatic product 25-hydroxycholesterol
por: Wang, Yuyang, et al.
Publicado: (2023)

What Can Be Learned From Crowdsourced Population Asparagus Urinary Odor Kinetics?
por: Facius, Axel, et al.
Publicado: (2019)

24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation
por: Sun, Min-Yu, et al.
Publicado: (2017)

Model‐Based Approach to Predict Adherence to Protocol During Antiobesity Trials
por: Sharma, Vishnu D., et al.
Publicado: (2017)

Cholesterol-25-hydroxylase Is a Chicken ISG That Restricts ALV-J Infection by Producing 25-hydroxycholesterol
por: Xie, Tingting, et al.
Publicado: (2019)

Regulation of Th17/Treg Balance by 27-Hydroxycholesterol and 24S-Hydroxycholesterol Correlates with Learning and Memory Ability in Mice
por: Wang, Tao, et al.
Publicado: (2022)

A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (ELEKTRA)
por: Hahn, Cecil D., et al.
Publicado: (2022)

Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects
por: Wang, Shining, et al.
Publicado: (2021)

24(S)-Hydroxycholesterol induces ER dysfunction-mediated unconventional cell death
por: Urano, Yasuomi, et al.
Publicado: (2019)

Up-regulation of cholesterol 24-hydroxylase following hypoxia-ischemia in neonatal mouse brain
por: Lu, Fuxin, et al.
Publicado: (2018)

24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo
por: Theofilopoulos, Spyridon, et al.
Publicado: (2019)

A case study of a patient‐centered reverse translational systems‐based approach to understand adverse event profiles in drug development
por: Kim, Sarah, et al.
Publicado: (2022)

Application of a patient‐centered reverse translational systems‐based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors
por: Kim, Sarah, et al.
Publicado: (2022)

Molecular basis for the recognition of 24-(S)-hydroxycholesterol by integrin αvβ3
por: Gc, Jeevan B., et al.
Publicado: (2023)

Role of cholesterol 24S-hydroxylase gene polymorphism (rs754203) in primary open angle glaucoma
por: Mossböck, Georg, et al.
Publicado: (2011)

Is It Possible to Improve Memory Function by Upregulation of the Cholesterol 24S-Hydroxylase (CYP46A1) in the Brain?
por: Maioli, Silvia, et al.
Publicado: (2013)

Preclinical characterization of [(18)F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase
por: Koike, Tatsuki, et al.
Publicado: (2021)

Excitotoxicity increases the release of 24S-hydroxycholesterol via CYP46A1 activation
por: Sodero, Alejandro, et al.
Publicado: (2013)

Additive neuroprotective effects of 24(S)-hydroxycholesterol and allopregnanolone in an ex vivo rat glaucoma model
por: Ishikawa, Makoto, et al.
Publicado: (2018)

24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome
por: Björkhem, Ingemar, et al.
Publicado: (2018)

Integrated stress response is involved in the 24(S)-hydroxycholesterol-induced unconventional cell death mechanism
por: Urano, Yasuomi, et al.
Publicado: (2022)

No relevant cardiac, pharmacokinetic or safety interactions between roflumilast and inhaled formoterol in healthy subjects: an open-label, randomised, actively controlled study
por: de Mey, Christian, et al.
Publicado: (2011)

Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on β-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells
por: Prasanthi, Jaya RP, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qulnh2qp2vn0fvvsck347p2upp